Prediabetes Remission Halves Heart Risk

Halving the risk of serious cardiovascular events, including heart attack and heart failure, is possible for those with prediabetes by returning blood glucose levels to normal. A recent study published in 'The Lancet Diabetes and Endocrinology' indicates that achieving prediabetes remission, defined by normal blood glucose, should be a primary clinical target.

Researchers identified a fasting blood glucose level below 97 milligrams per deciliter as a reliable marker for long-term reduced heart disease risk, applicable across diverse populations. This discovery could establish a fourth crucial pillar in cardiovascular prevention, alongside blood pressure control, LDL cholesterol management, and smoking cessation.

The long-term benefits of prediabetes remission are substantial, potentially offering protection against cardiovascular death and hospitalization for heart failure for decades. Experts suggest that actively targeting remission in prediabetes offers a powerful new strategy for preventing serious heart conditions.